Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Program: Scientific Session
General Topic: Clinical

More Than the Sum of Parts: A Roadmap to Target Social Risk Factors in Rheumatology

Tuesday, October 28, 2025
4:00 PM - 5:00 PM Central Time
CE: 1

    Moderator(s)

  • CF

    Candace Feldman, MD, MPH, ScD

    Brigham and Women's Hospital
    Boston, MA, United States

    Disclosure(s): Bain Capital, LP: Consultant (Ongoing); BMS Foundation: Grant/Research Support (Ongoing); Bristol-Myers Squibb Foundation: Grant/Research Support (Ongoing); Curio Bioscience: My husband is one of the founders and will receive equity (but has not received anything to date). (Ongoing); Harvard Pilgrim: Consultant (Ongoing); OM1, Inc.: Consultant (Ongoing); Pfizer: Grant/Research Support (Ongoing); Pfizer Pharmaceuticals: Grant/Research Support (Ongoing)

    • Session Coordinator(s)

  • RS

    Reema Syed, MD, MBBS

    Washington University School of Medicine in Saint Louis
    olivette, Missouri, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • AA

    Anca Askanase, MD, MPH

    Director
    Columbia University Medical Center
    New York, NY, United States

    Disclosure(s): Alumis: Advisor or Review Panel Member (Ongoing); Amgen: Advisor or Review Panel Member (Terminated, August 15, 2024); AstraZeneca: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Cabaletta: Grant/Research Support (Ongoing); Genentech: Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Idorsia: Grant/Research Support (Ongoing); Janssen: Advisor or Review Panel Member (Ongoing); NKARTA: Grant/Research Support (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); Sanofi: Grant/Research Support (Ongoing); UCB: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing)

  • KS

    Kai Sun, MD, MS, RhMSUS

    Duke University
    Durham, NC, United States

    Disclosure(s): Aurinia: Consultant (Terminated)

This session will bring together experts who will share their experiences in: 1) identifying key social risk factors that contribute to the health of patients with rheumatic diseases. 2) developing a roadmap to partner with other disciplines, health system administrators, social services, and policymakers to screen for and address social risk factors in rheumatology-focused healthcare settings, and 3) developing successful interventions, with a focus on facilitators and barriers for screening and addressing social risk factor across different rheumatology practices and settings.

Learning Objectives:

  • Identify key social risk factors that contribute to care access challenges and poor health outcomes in people with rheumatic diseases.
  • Describe the rationale to screen for social risk factors in rheumatology practices and identify multidisciplinary strategies to build support for implementation by partnering with health system administrators and advocates.
  • Develop practical approaches to address social risk factors in rheumatic diseases, including identifying facilitators and barriers to intervention implementation, and outlining customizable strategies for a scalable plan within your clinical practice.

Presentations:

  • 4:00 PM - 5:00 PM Central Time
    Panel Discussion

    Panelist: Jennifer Rogers, MD – Duke

    Panelist: Kimberly DeQuattro, MD – University of Pennsylvania

    Panelist: Shivani Garg, MD, MS – University of Madison, School of Medicine and Public Health